ORIC Pharmaceuticals (ORIC) PT Raised to $15 at Oppenheimer
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $14.20 +2.31%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler raised the price target on ORIC Pharmaceuticals (NASDAQ: ORIC) to $15.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Palmer Square Capital BDC (PSBD) PT Lowered to $10.25 at BofA Securities
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
